VGI Health Technology (XNEC:VTL) ROE % Adjusted to Book Value : 0.00% (As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology ROE % Adjusted to Book Value?

VGI Health Technology's ROE % for the quarter that ended in . 20 was 0.00%. VGI Health Technology's PB Ratio for the quarter that ended in . 20 was N/A. VGI Health Technology's ROE % Adjusted to Book Value for the quarter that ended in . 20 was N/A.

VGI Health Technology ROE % Adjusted to Book Value Historical Data

The historical data trend for VGI Health Technology's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology ROE % Adjusted to Book Value Chart

VGI Health Technology Annual Data

Trend

ROE % Adjusted to Book Value

VGI Health Technology Semi-Annual Data

ROE % Adjusted to Book Value

Competitive Comparison of VGI Health Technology's ROE % Adjusted to Book Value

For the Biotechnology subindustry, VGI Health Technology's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VGI Health Technology's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VGI Health Technology's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where VGI Health Technology's ROE % Adjusted to Book Value falls into.

VGI Health Technology ROE % Adjusted to Book Value Calculation

VGI Health Technology's ROE % Adjusted to Book Value for the fiscal year that ended in . 20 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

VGI Health Technology's ROE % Adjusted to Book Value for the quarter that ended in . 20 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

VGI Health Technology ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

VGI Health Technology (XNEC:VTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003

Website

https://www.vgiht.com

VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines